Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,774
datasets available to search
ShareScore release 0.9.0
Dataset results
2,774 results for “Agent”
GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer
ClinicalTrials.gov study NCT06046274. IPD Sharing: NO. Countries: 6. Publications: 0.
Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy
ClinicalTrials.gov study NCT03155113. IPD Sharing: NO. Countries: 1. Publications: 0.
Optimization of Contrast Agent Dose in CT With Lean Body Weight
ClinicalTrials.gov study NCT03384979. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparisons Of Different Antiplaque Agents On Gingivitis In Orthodontic Patients
ClinicalTrials.gov study NCT06305546. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents
ClinicalTrials.gov study NCT00546325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients
ClinicalTrials.gov study NCT00132223. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer
ClinicalTrials.gov study NCT00508586. IPD Sharing: Not stated. Countries: 1. Publications: 0.
KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (P
ClinicalTrials.gov study NCT04165083. IPD Sharing: YES. Countries: 7. Publications: 0.
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06106945. IPD Sharing: YES. Countries: 8. Publications: 0.
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
ClinicalTrials.gov study NCT05562830. IPD Sharing: YES. Countries: 10. Publications: 0.
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
ClinicalTrials.gov study NCT07276399. IPD Sharing: YES. Countries: 7. Publications: 0.
Comparison of Pureed Rice Using a Gelling Agent and Standard Pureed Rice
ClinicalTrials.gov study NCT03163355. IPD Sharing: NO. Countries: 1. Publications: 0.
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
ClinicalTrials.gov study NCT06686108. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
ClinicalTrials.gov study NCT05135975. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies.
ClinicalTrials.gov study NCT05841771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
ClinicalTrials.gov study NCT06686394. IPD Sharing: YES. Countries: 6. Publications: 0.
Influence of Shared-Decision Making in Reducing Decision Conflict on the Choice of Awakening Agent After General Anesthesia
ClinicalTrials.gov study NCT04272177. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)
ClinicalTrials.gov study NCT00773409. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)
ClinicalTrials.gov study NCT04490031. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their R
ClinicalTrials.gov study NCT03023852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.